TKNO · Alpha Teknova, Inc. · Webcasts, Transcripts & Audio
$7.81
-0.07 (-0.89%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$491.27M
Shares
62.90M
Volume · Nov 19
266.85K
Avg daily vol (3M)
435.39K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Alpha Teknova, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Alpha Teknova, Inc. (TKNO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-04
Alpha Teknova, Inc. (TKNO) Q3 2026 Earnings Call Transcript
Confident tone
Biotech funding and biopharma recovery
Clinical solutions and GMP products
Revenue growth and custom products
Revenue
$12.70M
▲ 21.5% YoY Diluted EPS
$-0.06
Gross margin
38.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
Alpha Teknova, Inc. (TKNO) Q2 2026 Earnings Call Transcript
Confident tone
Biotech funding environment
Clinical pipeline and commercialization tailwinds
BuildPet / BuildTech AI configurator launch
Revenue
$12.19M
▲ 18.5% YoY Diluted EPS
$-0.06
Gross margin
40.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript
Positive tone
Revenue growth and end market stabilization
Clinical Solutions momentum
Path to 2027 ~20% revenue growth
Revenue
$11.08M
▲ 13.1% YoY Diluted EPS
$-0.08
Gross margin
34.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-19
Alpha Teknova, Inc. (TKNO) March 19, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-26
Alpha Teknova, Inc. (TKNO) Q4 2025 Earnings Call Transcript
Confident tone
GMP clinical / therapy growth
Cash usage and path to EBITDA positive
Margin and operating leverage outlook
Revenue
$9.98M*
▲ 7.8% YoY Gross margin
32.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Alpha Teknova, Inc. (TKNO) Q3 2025 Earnings Call Transcript
Positive tone
Clinical Solutions / GMP pipeline
Lab Essentials and catalog product growth
Biopharma end-market weakness
Revenue
$10.45M
▲ 9.2% YoY Diluted EPS
$-0.08
Gross margin
30.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Alpha Teknova, Inc. (TKNO) Q2 2025 Earnings Call Transcript
Confident tone
Catalog products growth
Custom clinical reagents
Guidance and outlook
Revenue
$10.29M
▲ 7% YoY Diluted EPS
$-0.07
Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Alpha Teknova, Inc. (TKNO) Q1 2025 Earnings Call Transcript
Positive tone
Custom products to biopharma (clinical)
Collaboration / M&A (Pluristics)
Custom products to life science tools and diagnostics
Revenue
$9.79M
▲ 5.4% YoY Diluted EPS
$-0.09
Gross margin
30.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call
Revenue
$9.27M*
▲ 17.8% YoY Gross margin
23.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Alpha Teknova, Inc. (TKNO) Q3 2024 Earnings Call Transcript
Positive tone
Revenue Growth and Clinical Solutions Momentum
Biopharma Market Environment
Gross Margin and Inventory Charge
Revenue
$9.58M
▲ 17.2% YoY Diluted EPS
$-0.15
Gross margin
0.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-09
Alpha Teknova, Inc. (TKNO) Q2 2024 Earnings Call Transcript
Positive tone
Revenue performance and guidance
New product launches (RUO+ and Express-Tek)
Market environment and biotech funding
Revenue
$9.61M
▼ 16.6% YoY Diluted EPS
$-0.13
Gross margin
29.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Alpha Teknova, Inc. (TKNO) Q1 2024 Earnings Call Transcript
Positive tone
Revenue and 2024 Guidance
Gross Margin Leverage
Capital Expenditures
Revenue
$9.29M
▲ 1.9% YoY Diluted EPS
$-0.20
Gross margin
23.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-11
Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Call Transcript
Cautious tone
Clinical Solutions / cell and gene therapy growth
Lab Essentials SKU rationalization and customer count
Gross margin compression
Revenue
$7.87M*
▼ 0.3% YoY Gross margin
17.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript
Revenue
$8.17M
▼ 23.6% YoY Diluted EPS
$-0.34
Gross margin
18.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Alpha Teknova, Inc. (TKNO) Q2 2023 Earnings Call Transcript
Revenue
$11.53M
▼ 1.4% YoY Diluted EPS
$-0.25
Gross margin
43.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript
Revenue
$9.12M
▼ 18.2% YoY Diluted EPS
$-0.31
Gross margin
26.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript
Revenue
$7.89M*
▼ 21.9% YoY Gross margin
26.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript
Revenue
$10.69M
▲ 13.8% YoY Diluted EPS
$-0.80
Gross margin
44.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Alpha Teknova, Inc. (TKNO) Q2 2022 Earnings Call Transcript
Revenue
$11.69M
▲ 40.6% YoY Diluted EPS
$-0.22
Gross margin
44.9%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Alpha Teknova, Inc. (TKNO) Q1 2022 Earnings Call Transcript
Revenue
$11.15M
▲ 22.8% YoY Diluted EPS
$-0.20
Gross margin
48.0%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-15
Alpha Teknova, Inc. (TKNO) Q4 2021 Earnings Call Transcript
Revenue
$10.11M*
Gross margin
49.2%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Alpha Teknova, Inc. (TKNO) Q3 2021 Earnings Call Transcript
Revenue
$9.39M
▲ 4.5% YoY Diluted EPS
$-0.12
▼ 271.4% YoY Gross margin
45.4%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
Alpha Teknova, Inc. (TKNO) Q2 2021 Earnings Call
Revenue
$8.31M
▲ 37.5% YoY Diluted EPS
$-0.52
▼ 2700% YoY Gross margin
40.3%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–23 of 23 webcasts
Key facts
CIK
1850902
CUSIP
02080L102
13F (30d)
118 filings
105 filers
Visit website
Investor relations